Optimizing therapeutic outcomes: preconditioning strategies for MSC-derived extracellular vesicles
Mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles (MSC-EVs) are increasingly recognized for their therapeutic potential in regenerative medicine, driven by their capabilities in immunomodulation and tissue repair. However, MSCs present risks such as immunogenic responses, malignan...
Saved in:
Main Authors: | Yuqi Song, Fengrui Liang, Weikun Tian, Erin Rayhill, Liping Ye, Xinghan Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1509418/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracecellulr vesicles (EVs) microRNAs (miRNAs) derived from mesenchymal stem cells (MSCs) in osteoarthritis (OA); detailed role in pathogenesis and possible therapeutics
by: Seyede Sara Pakdaman Kolour, et al.
Published: (2025-02-01) -
miRNA in blood-brain barrier repair: role of extracellular vesicles in stroke recovery
by: Vojtech Sprincl, et al.
Published: (2025-02-01) -
Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
by: Qian Zhu, et al.
Published: (2025-01-01) -
Mesenchymal stem cells and their extracellular vesicle therapy for neurological disorders: traumatic brain injury and beyond
by: Aref Yarahmadi, et al.
Published: (2025-02-01) -
MSC-EVs and UCB-EVs promote skin wound healing and spatial transcriptome analysis
by: Ruonan Li, et al.
Published: (2025-02-01)